Delivery Order SPE2DX22D0019-SPE2D826FBL02

The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,173.44 to AmerisourceBergen Drug Corp on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. The delivery order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive range of medical products through the Defense Logistics Agency, including brand-name and generic medications, vaccines, medical devices, and specialized pharmaceuticals across multiple therapeutic domains. The company's SPE2DX prime IDV serves as a global pharmaceutical support vehicle enabling supply to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order reflects the company's ongoing role as a preferred vendor under the DLA's pharmaceutical procurement strategy, which is transitioning to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards anticipated across different contractors.